Cargando…
Serological Response after Two Doses of Sars-Cov-2 Vaccines in CML Patients - a Prospective Study of a Brazilian Center
Autores principales: | Mourão Toreli, Ana Carolina, Fechio, Leonardo, Duarte, Adriana Silva Santos, Basso, Audrey, Duarte, Gislaine B O, Medina, Samuel de Souza, Amarante, Guilherme Brasil Duffles, Pericole, Fernando Vieira, Benites, Bruno Deltreggia, Zulli, Roberto, Souza, Carmino Antonio, Addas Carvalho, Marcelo, Pagnano, Katia B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665222/ http://dx.doi.org/10.1182/blood-2022-168108 |
Ejemplares similares
-
PB1977: EVALUATION OF ANTIBODY RESPONSES AMONG FIVE DIFFERENT SARS-COV-2 VACCINES IN CHRONIC MYELOID LEUKEMIA PATIENTS – A REAL-WORLD STUDY
por: Toreli, Ana Carolina, et al.
Publicado: (2023) -
A Survey Conducted during COVID-19 Pandemic Among Brazilian Chronic Myeloid Leukemia and Philadelphia-Negative Myeloproliferative Neoplasms Patients
por: Fechio, Leonardo, et al.
Publicado: (2021) -
COVID-19 - RESULTADOS DE QUESTIONÁRIOS APLICADOS EM PACIENTES COM LEUCEMIA MIELOIDE CRÔNICA DURANTE A PANDEMIA
por: Fechio, L, et al.
Publicado: (2021) -
Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome
por: Benites, Bruno Deltreggia, et al.
Publicado: (2013) -
PB1891: VARIANT PHILADELPHIA CHROMOSOME IN CML
por: Bouayed Abdelmoula, N., et al.
Publicado: (2022)